SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla launches ‘RT-Direct’ multiplex COVID-19 RT PCR Test kit in India

10 May 2022 Evaluate

Cipla has launched ‘RT-Direct’ multiplex COVID-19 RT PCR Test kit in India, in partnership with Genes2Me. With this, the company is expanding its diagnostics offering to bring more advance and innovative products. The company will be responsible for the distribution of RT Direct kits in India and has commenced supply of the same.

This kit is validated at the Indian Council of Medical Research (ICMR) approved Centre. It is based on the ‘gold standard RT-PCR method with coverage of three target genes specific to SARS-COV-2 along with IC, which is much advanced than others having 1 or 2 target genes. This greatly increases the sensitivity of the RTPCR test.

RT-Direct test protocol does not require any RNA extraction process, making it faster and helps deliver results in just 45 minutes. It will also increase the throughput of any testing lab by threefold compared to the normal RT-PCR test protocol time of 120-150 minutes.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1231.60 -6.70 (-0.54%)
20-Apr-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.75
Dr. Reddys Lab 1233.95
Cipla 1231.60
Zydus Lifesciences 938.70
Lupin 2328.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×